Answers are grounded in this paper and cite their sources.
The ability of cytotoxic lymphocytes (CL) to eliminate virus-infected or cancerous target cells through the granule exocytosis death pathway is critical to immune homoeostasis. Congenital loss of CL function due to bi-allelic mutations in PRF1, UNC13D, STX11 or STXBP2 leads to a potentially fatal immune dysregulation, familial haemophagocytic lymphohistiocytosis (FHL). This occurs due to the failure of CLs to release functional pore-forming protein perforin and, therefore, inability to kill the target cell. Bi-allelic mutations in partner proteins STXBP2 or STX11 impair CL cytotoxicity due to failed docking/fusion of cytotoxic secretory granules to the synaptic cleft between the lymphocyte and a target cell. One unique feature of STXBP2- and STX11- deficient patient cytotoxic lymphocytes is that their short-term in vitro treatment with a low concentration of IL-2 partially or completely restores natural killer cell degranulation and cytotoxicity, suggesting the existence of a secondary, yet unknown, pathway for secretory granule exocytosis. In the current report, we studied natural killer and T cell function in an individual with late presentation of FHL due to hypomorphic bi-allelic mutations in STXBP2. Intriguingly, in addition to the expected alterations in the STXBP2 and STX11 proteins, we also observed a concomitant significant reduction in the expression of homologous STXBP1 protein, which had never been implicated in CL function. Further analysis of human NK and T cells demonstrated a functional role for STXBP1 in natural killer and CD8+ T-cell cytotoxicity, where it appears to be responsible for as much as 50% of their cytotoxic activity. This discovery provides an explanation for a paradoxical recovery of natural killer cell function in patients with STXBP2 (and, potentially, STX11) mutations, and suggests a unique and previously unappreciated interplay between STXBP/Munc proteins regulating the same essential granule exocytosis pathway.
No takes yet. Share an insight, caveat, or question.
Noori et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: